Physiopathologic factors resulting in poor outcome in childhood severe malaria in Cameroon

Inocent Gouado1, Joël Bertrand Pankoui M, Honoré Fotso K

  • 1Department of Biochemistry, University of Douala, Douala, Cameroon. gouadoi@yahoo.fr

Insights

Lactate and nitric oxide (NO) levels indicate poor prognosis in pediatric malaria. While creatinine, urea, and bilirubin were not significant predictors, they can help monitor treatment response in severe cases.

Area of Science:

  • Pediatric infectious diseases
  • Biochemistry
  • Clinical diagnostics

Background:

  • Malaria remains a significant global health challenge, particularly affecting children.
  • Identifying reliable biomarkers for disease severity and prognosis is crucial for effective management.

Purpose of the Study:

  • To evaluate plasma levels of creatinine, urea, bilirubin, lactic acid, and nitric oxide (NO) in children with malaria.
  • To identify indices that predict disease severity and fatal outcomes in pediatric malaria patients.

Main Methods:

  • Plasma samples were collected from pediatric malaria patients (0-15 years).
  • Spectrophotometry was used to determine levels of creatinine, urea, bilirubin, lactic acid, and nitric oxide.
  • Clinical data was recorded for correlation with biochemical markers.

Main Results:

  • Elevated lactate levels were observed in severe malaria groups (cerebral malaria and anemia).
  • Nitric oxide (NO) levels were significantly higher in all malaria groups compared to controls, especially in severe cases.
  • Creatinine, urea, and bilirubin levels were generally within normal ranges, with some exceptions for urea in specific patient subgroups.

Conclusions:

  • Lactate and nitric oxide (NO) are identified as key indicators of poor prognosis in pediatric malaria.
  • While not significant predictors of outcome, creatinine, urea, and bilirubin can be useful for assessing treatment response in severe malaria.
Abstract

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...